Resectable Intrahepatic Cholangiocarcinoma clinical trials

Explore recruiting resectable intrahepatic cholangiocarcinoma clinical trials.

Recruiting resectable intrahepatic cholangiocarcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Resectable Intrahepatic Cholangiocarcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PRODIGE 118 - PEHRICCA : PErioperative CISGEM plus RILVEGOSTOMIG in High-Risk resectable Intrahepatic CholangioCarcinoma Phase II single arm study -mutlicenter

France

Phase II and Phase III (Integrated) EU CTIS Study details

Resectable Intrahepatic Cholangiocarcinoma trials by city

Resectable Intrahepatic Cholangiocarcinoma in Toronto Resectable Intrahepatic Cholangiocarcinoma in Vancouver Resectable Intrahepatic Cholangiocarcinoma in Montreal Resectable Intrahepatic Cholangiocarcinoma in Calgary Resectable Intrahepatic Cholangiocarcinoma in Edmonton Resectable Intrahepatic Cholangiocarcinoma in Ottawa Resectable Intrahepatic Cholangiocarcinoma in Winnipeg Resectable Intrahepatic Cholangiocarcinoma in Quebec City Resectable Intrahepatic Cholangiocarcinoma in Hamilton Resectable Intrahepatic Cholangiocarcinoma in Kitchener Resectable Intrahepatic Cholangiocarcinoma in London Resectable Intrahepatic Cholangiocarcinoma in Halifax Resectable Intrahepatic Cholangiocarcinoma in New York Resectable Intrahepatic Cholangiocarcinoma in Los Angeles Resectable Intrahepatic Cholangiocarcinoma in Chicago Resectable Intrahepatic Cholangiocarcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease